Works by de Bono, Johann

Results: 104
    1
    2

    Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 167, doi. 10.1007/s00280-009-1020-y
    By:
    • Chia-Chi Lin;
    • Beeram, Muralidhar;
    • Rowinsky, Eric K.;
    • Takimoto, Chris H.;
    • Ng, Chee M.;
    • Geyer Jr., Charles E.;
    • Denis, Louis J.;
    • De Bono, Johann S.;
    • Hao, Desiree;
    • Tolcher, Anthony W.;
    • Rha, Sun-Young;
    • Jolivet, Jacques;
    • Patnaik, Amita
    Publication type:
    Article
    3
    4
    5
    6
    7

    Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkz093
    By:
    • Piha-Paul, Sarina A;
    • Hann, Christine L;
    • French, Christopher A;
    • Cousin, Sophie;
    • Braña, Irene;
    • Cassier, Phillippe A;
    • Moreno, Victor;
    • Bono, Johann S de;
    • Harward, Sara Duckworth;
    • Ferron-Brady, Geraldine;
    • Barbash, Olena;
    • Wyce, Anastasia;
    • Wu, Yuehui;
    • Horner, Thierry;
    • Annan, Meg;
    • Parr, Nigel J;
    • Prinjha, Rabinder K;
    • Carpenter, Christopher L;
    • Hilton, John;
    • Hong, David S
    Publication type:
    Article
    8

    Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkaa003
    By:
    • Halabi, Susan;
    • Dutta, Sandipan;
    • Tangen, Catherine M;
    • Rosenthal, Mark;
    • Petrylak, Daniel P;
    • Thompson, Ian M;
    • Chi, Kim N;
    • Bono, Johann S De;
    • Araujo, John C;
    • Logothetis, Christopher;
    • Eisenberger, Mario A;
    • Quinn, David I;
    • Fizazi, Karim;
    • Morris, Michael J;
    • Higano, Celestia S;
    • Tannock, Ian F;
    • Small, Eric J;
    • Kelly, William Kevin
    Publication type:
    Article
    9

    Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysis.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 5, p. 441, doi. 10.1093/jjco/hyac015
    By:
    • Matsubara, Nobuaki;
    • Nishimura, Kazuo;
    • Kawakami, Satoru;
    • Joung, Jae Young;
    • Uemura, Hiroji;
    • Goto, Takayuki;
    • Kwon, Tae Gyun;
    • Sugimoto, Mikio;
    • Kato, Masashi;
    • Wang, Shian-Shiang;
    • Pang, See-Tong;
    • Chen, Chung-Hsin;
    • Fujita, Tomoko;
    • Nii, Masahiro;
    • Shen, Liji;
    • Dujka, Melanie;
    • Hussain, Maha;
    • Bono, Johann de
    Publication type:
    Article
    10

    Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1287, doi. 10.1093/jjco/hyab028
    By:
    • Suzuki, Hiroyoshi;
    • Castellano, Daniel;
    • Bono, Johann de;
    • Sternberg, Cora N;
    • Fizazi, Karim;
    • Tombal, Bertrand;
    • Wülfing, Christian;
    • Foster, Meredith C;
    • Ozatilgan, Ayse;
    • Geffriaud-Ricouard, Christine;
    • Wit, Ronald de
    Publication type:
    Article
    11
    12

    Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients.

    Published in:
    Cancers, 2021, v. 13, n. 10, p. 2334, doi. 10.3390/cancers13102334
    By:
    • Lozano, Rebeca;
    • Lorente, David;
    • Aragon, Isabel M.;
    • Romero-Laorden, Nuria;
    • Nombela, Paz;
    • Mateo, Joaquim;
    • Reid, Alison H. M.;
    • Cendón, Ylenia;
    • Bianchini, Diletta;
    • Llacer, Casilda;
    • Sandhu, Shahneen K.;
    • Sharp, Adam;
    • Rescigno, Pasquale;
    • Garcés, Teresa;
    • Pacheco, Maria I.;
    • Flohr, Penelope;
    • Massard, Christophe;
    • López-Casas, Pedro P.;
    • Castro, Elena;
    • de Bono, Johann S.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours.

    Published in:
    2020
    By:
    • de Bono, Johann;
    • Lin, Chia-Chi;
    • Chen, Li-Tzong;
    • Corral, Jesus;
    • Michalarea, Vasiliki;
    • Rihawi, Karim;
    • Ong, Michael;
    • Lee, Jih-Hsiang;
    • Hsu, Chih-Hung;
    • Yang, James Chih-Hsin;
    • Shiah, Her-Shyong;
    • Yen, Chia-Jui;
    • Anthoney, Alan;
    • Jove, Maria;
    • Buschke, Susanne;
    • Fuertig, René;
    • Schmid, Ulrike;
    • Goeldner, Rainer-Georg;
    • Strelkowa, Natalja;
    • Huang, Dennis Chin-Lun
    Publication type:
    journal article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor.

    Published in:
    Journal of Pathology, 2013, v. 229, n. 3, p. 422, doi. 10.1002/path.4140
    By:
    • Barber, Louise J;
    • Sandhu, Shahneen;
    • Chen, Lina;
    • Campbell, James;
    • Kozarewa, Iwanka;
    • Fenwick, Kerry;
    • Assiotis, Ioannis;
    • Rodrigues, Daniel Nava;
    • Reis-Filho, Jorge S;
    • Moreno, Victor;
    • Mateo, Joaquin;
    • Molife, L Rhoda;
    • De Bono, Johann;
    • Kaye, Stan;
    • Lord, Christopher J;
    • Ashworth, Alan
    Publication type:
    Article
    32
    33
    34
    35
    36

    A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma.

    Published in:
    Science Translational Medicine, 2011, v. 3, n. 85, p. 1, doi. 10.1126/scitranslmed.3002004
    By:
    • Suwaki, Natsuko;
    • Vanhecke, Elsa;
    • Atkins, Katelyn M.;
    • Graf, Manuela;
    • Swabey, Katherine;
    • Huang, Paul;
    • Schraml, Peter;
    • Moch, Holger;
    • Cassidy, Amy Mulick;
    • Brewer, Daniel;
    • Al-Lazikani, Bissan;
    • Workman, Paul;
    • De-Bono, Johann;
    • Kaye, Stan B.;
    • Larkin, James;
    • Gore, Martin. E.;
    • Sawyers, Charles L.;
    • Nelson, Peter;
    • Beer, Tomasz M.;
    • Geng, Hao
    Publication type:
    Article
    37
    38
    39
    40
    41

    Systematic study of tissue factor expression in solid tumors.

    Published in:
    Cancer Reports, 2023, v. 6, n. 2, p. 1, doi. 10.1002/cnr2.1699
    By:
    • de Bono, Johann S.;
    • Harris, Jeffrey R.;
    • Burm, Saskia M.;
    • Vanderstichele, Adriaan;
    • Houtkamp, Mischa A.;
    • Aarass, Saida;
    • Riisnaes, Ruth;
    • Figueiredo, Ines;
    • Nava Rodrigues, Daniel;
    • Christova, Rossitza;
    • Olbrecht, Siel;
    • Niessen, Hans W. M.;
    • Ruuls, Sigrid R.;
    • Schuurhuis, Danita H.;
    • Lammerts van Bueren, Jeroen J.;
    • Breij, Esther C. W.;
    • Vergote, Ignace
    Publication type:
    Article
    42
    43
    44

    Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476).

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 3, p. 422, doi. 10.1002/ijc.34018
    By:
    • James, Nicholas D.;
    • Clarke, Noel W.;
    • Cook, Adrian;
    • Ali, Adnan;
    • Hoyle, Alex P.;
    • Attard, Gerhardt;
    • Brawley, Christopher D.;
    • Chowdhury, Simon;
    • Cross, William R.;
    • Dearnaley, David P.;
    • de Bono, Johann S.;
    • Diaz‐Montana, Carlos;
    • Gilbert, Duncan;
    • Gillessen, Silke;
    • Gilson, Clare;
    • Jones, Rob J.;
    • Langley, Ruth E.;
    • Malik, Zafar I.;
    • Matheson, David J.;
    • Millman, Robin
    Publication type:
    Article
    45

    Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 6, p. 993, doi. 10.1002/ijc.33861
    By:
    • Cousin, Sophie;
    • Blay, Jean‐Yves;
    • Garcia, Irene Braña;
    • de Bono, Johann S.;
    • Le Tourneau, Christophe;
    • Moreno, Victor;
    • Trigo, Jose;
    • Hann, Christine L.;
    • Azad, Arun A.;
    • Im, Seock‐Ah;
    • Cassier, Philippe A.;
    • French, Christopher A.;
    • Italiano, Antoine;
    • Keedy, Vicki L.;
    • Plummer, Ruth;
    • Sablin, Marie‐Paule;
    • Hemming, Matthew L.;
    • Ferron‐Brady, Geraldine;
    • Wyce, Anastasia;
    • Khaled, Ahmed
    Publication type:
    Article
    46
    47
    48
    49

    Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial.

    Published in:
    Trials, 2012, v. 13, n. 1, p. 168, doi. 10.1186/1745-6215-13-168
    By:
    • Sydes, Matthew R.;
    • Parmar, Mahesh K. B.;
    • Mason, Malcolm D.;
    • Clarke, Noel W.;
    • Amos, Claire;
    • Anderson, John;
    • de Bono, Johann;
    • Dearnaley, David P.;
    • Dwyer, John;
    • Green, Charlene;
    • Jovic, Gordana;
    • Ritchie, Alastair W. S.;
    • Russell, J. Martin;
    • Sanders, Karen;
    • Thalmann, George;
    • James, Nicholas D.
    Publication type:
    Article
    50